| Ytd | -48.70% | |
| 1y | -17.22% |
| Open | 8.61 | Prev Close | 8.57 | Low | 8.46 | High | 8.82 | Mkt Cap | 688.47M |
| Vol | 0.00 | Avg Vol | 1.31M | EPS | -1.47 | P/E | -5.79 | Forward P/E | 7.60 |
| Beta | 0.61 | Short Ratio | 9.36 | Inst. Own | 83.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 10.48 | 200-d Avg | 12.52 | 1yr Est | 23.70 |
Phathom Pharmaceuticals' revised FY 2026 revenue outlook of $310 million -- $325 million came in bel
NEW YORK--(BUSINESS WIRE)--Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) shareholders took losses aft
/PRNewswire/ -- Investors in Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) were told the Company's fu
Phathom Pharmaceuticals, Inc. (PHAT) Q2 2026 Earnings Call Transcript
Phathom Pharmaceuticals guided FY 2026 revenue as high as $345 million while building out a sales fo
Phathom Pharmaceuticals NASDAQ: PHAT reported second-quarter 2026 revenue growth of 88% year over ye
Phathom Pharmaceuticals, Inc. (PHAT) reported break-even quarterly earnings per share versus the Zac
FLORHAM PARK, N.J., July 30, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT),
Management to host conference call on Thursday, July 30, 2026, at 8:00 am EDT Management to host con
This trial is the first large, placebo-controlled clinical trial of an acid suppression treatment in
Phathom Pharmaceuticals, Inc. (PHAT) Presents at Goldman Sachs 47th Annual Global Healthcare Confere
FLORHAM PARK, N.J., May 22, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a
FLORHAM PARK, N.J., May 20, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a
FLORHAM PARK, N.J., May 01, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a
Phathom Pharmaceuticals, Inc. (PHAT) Q1 2026 Earnings Call Transcript
Phathom Pharmaceuticals, Inc. (PHAT) came out with a quarterly loss of $0.18 per share versus the Za
FLORHAM PARK, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT),
Management to host conference call on Thursday, April 30, 2026, at 8:00 am EDT FLORHAM PARK, N.J., A
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT - Get Free Report) has received a consensus recommendati
FLORHAM PARK, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT),
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earning
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced a
On Friday, 469 companies hit new 52-week lows.
Gainers SeqLL Inc. (NASDAQ: SQL) shares jumped 120% to $1.85 after dropping around 39% on Thursda
Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatili
During Monday's trading, 1214 companies set new 52-week lows.
During Tuesday's session, 454 stocks hit new 52-week lows.
On Monday, 671 companies achieved new lows for the year.
Tuesday morning saw 454 companies set new 52-week lows.
During Friday's session, 445 companies made new 52-week lows.